Menu

1 / 2

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Independent·Matthew Perrone·8 days ago
#kpsTIDBB
Reading 0:00
15s threshold

Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday.

The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster medications used to treat obesity, diabetes and several other medical conditions. The class includes a dozen injectable or pill-based drugs, including widely used brands like Zepbound and Mounjaro.

The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.